AUGX

Investor Moves

Investor	Portfolio Value	Portfolio Change	Position Change	Avg Buy Price	Current Price
Ken GriffinCitadel Advisors $-1.6M ExitQ3 2024 $1.6M -- --
Jim SimonsRenaissance Technologies $-46.8K ExitQ3 2024 $47k -- --
Jim SimonsRenaissance Technologies $-328 ExitQ2 2024 $328 -- --

Trade AUGX

About Augmedix, Inc.

Augmedix, Inc. is a U.S.-based company specializing in remote medical documentation and offering live support to clinical professionals. Its comprehensive platform, comprising Augmedix Live and Augmedix Notes, streamlines the entire documentation process for patient encounters. This includes preparatory tasks like pre-charting and digitizing historical patient data prior to appointments. During the consultation, it generates essential medical notes, flags care gaps, provides HCC reminders, and produces after-visit summaries. Post-visit, the system facilitates crucial administrative duties such as medical coding, processing orders, and managing referrals. Clinicians can readily access these applications via mobile devices, including smartphones or specialized wearables like Google Glass. The company's clientele primarily consists of various health systems and distinct specialty groups. Founded in 2013, Augmedix maintains its corporate headquarters in San Francisco, California.

CEO: Emmanuel Krakaris
IPO Date: Mar 31, 2021

Market Data

Open: $2.34
High: $2.35
Low: $2.34
Volume: 23K
52W High: $6.25
52W Low: $0.73

Valuation

Market Cap: $116M
Enterprise Value: $97M

Financials

Free Cash Flow: $-19M
Revenue: $45M
Net Income: $-19M
Cash: $46M
Debt: $27M

Events

EarningsNov 4

EPS est. -0.15 · actual -0.1